热门资讯> 正文

AVRO比奥GAAP每股收益为-1.20美元

2024-11-08 13:21

AVROBIO(AVRO) 0
Tectonic Therapeutic Inc. Ordinary Shares(TECX) 0
富国银行(WFC) 0

AVROBIO press release (NASDAQ:TECX): Q3 GAAP EPS of -$1.20.
Cash and cash equivalents were $159.1 million as of September 30, 2024, expected to provide cash runway into mid-2027

More on AVROBIO

Tectonic Therapeutic: Interesting CV Disease Drug Developer
Tectonic draws bullish view at Wells Fargo on lead asset
Historical earnings data for AVROBIO
Financial information for AVROBIO

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。